CEPHALEXIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 36 adverse event reports in the FDA FAERS database where CEPHALEXIN was used for Psoriasis.
Most Reported Side Effects for CEPHALEXIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug hypersensitivity | 2,055 | 26.0% | 6 | 133 |
| Rash | 897 | 11.4% | 2 | 208 |
| Diarrhoea | 711 | 9.0% | 15 | 227 |
| Dyspnoea | 593 | 7.5% | 70 | 273 |
| Drug ineffective | 540 | 6.8% | 10 | 184 |
| Nausea | 521 | 6.6% | 6 | 175 |
| Pruritus | 499 | 6.3% | 0 | 106 |
| Urticaria | 404 | 5.1% | 2 | 51 |
| Vomiting | 393 | 5.0% | 5 | 124 |
| Hypersensitivity | 379 | 4.8% | 8 | 90 |
| Headache | 374 | 4.7% | 7 | 127 |
| Malaise | 372 | 4.7% | 6 | 109 |
| Dizziness | 356 | 4.5% | 4 | 73 |
| Anxiety | 348 | 4.4% | 61 | 133 |
| Fatigue | 345 | 4.4% | 9 | 73 |
Other Indications for CEPHALEXIN
Product used for unknown indication (2,776)
Urinary tract infection (544)
Cellulitis (303)
Infection (219)
Ill-defined disorder (87)
Localised infection (87)
Antibiotic therapy (84)
Malaise (77)
Vomiting (76)
Dizziness (74)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)